Takotsubo Syndrome: Clinical Trials

1 trial for Takotsubo Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Takotsubo Syndrome: new trials by email Literature Review of Takotsubo Syndrome trials Research Report on Takotsubo Syndrome

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.
Adenosine, Dipyridamole 200 mg, Apixaban 5 mg Oral Tablet - Takotsubo Syndrome
Phase 4RecruitingVastra Gotaland Region10002020-12-142024-12-02

Narrower conditions

Takotsubo Cardiomyopathy (1)

Broader conditions

Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Ventricular Dysfunction (1)  ·  Ventricular Dysfunction, Left (1)

Interventions

Adenosine (1)  ·  Dipyridamole (1)  ·  Tablets (1)  ·  apixaban (1)

Sponsors

Vastra Gotaland Region (1)

Countries

Denmark (1)  ·  Norway (1)  ·  Sweden (1)

Top investigators

Elmir Omerovic, MD PhD (1)

Results publications

PMID 36435233